Advertisement
Home Tags Cancer: Skin

Tag: Cancer: Skin

Excellent local control and cosmetic outcomes are observed in elderly patients receiving high dose-rate brachytherapy for early-stage nonmelanoma skin cancer of the head and neck region

RSNA: Brachytherapy Treats Skin Cancer in Elderly Patients

0
Brachytherapy alternative to Mohs surgery in early-stage nonmelanoma skin cancers of head, neck
Melanoma incidence seems to be decreasing in adolescents and young adults

Invasive Melanoma Incidence Decreasing in Teens, Young Adults

0
From 2006 to 2015, melanoma rates increased among adults ≥40 years, decreased in younger populations
For individuals with obesity

Bariatric Surgery Linked to Reduced Risk for Skin Cancer

0
For individuals with obesity, risk for skin cancer and melanoma significantly reduced with bariatric surgery
A skin cancer prevention program -- "SunSmart" -- can create lasting changes in sun protection behavior and contribute to the decline in melanoma rates

SunSmart Program Ups Sun Protection Behaviors

0
Findings based on decades-long study in Australia
Outcomes for nonmelanoma skin cancers are similar at one year

Outcomes Across Nonmelanoma Skin Cancer Treatments Similar

0
Brachytherapy and Mohs micrographic surgery show better cosmetic results
Second opinions rendered by dermatopathologists improve the reliability of melanocytic lesion diagnosis

Expert Second Opinions Up Reliability of Melanoma Diagnosis

0
In study, none of the second opinion strategies eliminated diagnostic misclassification
From 1995 to 2014

Rates of Head, Neck Melanoma Up in North American Youth

0
Risk for head, neck melanoma higher for male sex, older age, non-Hispanic white ethnicity
There is a dose-response association between indoor tanning and risk for cutaneous squamous cell carcinoma in women

Indoor Tanning May Up Risk for Squamous Cell Carcinoma

0
Dose-response association found between indoor tanning and SCC risk among women
More patients with advanced melanoma receiving nivolumab plus ipilimumab or nivolumab alone have sustained long-term survival at five years compared with those receiving ipilimumab alone

Nivolumab Therapy Prolongs Survival in Advanced Melanoma

0
Overall survival at five years longer with nivolumab + ipilimumab, nivolumab alone versus ipilimumab
Mohs micrographic surgery is associated with improved survival compared with traditional surgery with wide margin excision for stage I melanoma

Mohs Micrographic Surgery May Up Survival in Stage I Melanoma

0
Survival modestly improved compared with traditional surgery with wide margin excision